| # | Drug | Count |
|---|---|---|
| 0 | DEXAMETHASONE | 6758 |
| 1 | CYCLOPHOSPHAMIDE | 5972 |
| 2 | DEXAMETHASONE 1.5 MG | 5968 |
| 3 | LENALIDOMIDE | 4857 |
| 4 | RITUXIMAB | 4479 |
| 5 | CLOZAPINE | 4338 |
| 6 | METHOTREXATE SODIUM | 3802 |
| 7 | CARBOPLATIN | 3695 |
| 8 | PREDNISONE | 3673 |
| 9 | PALBOCICLIB | 3647 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DEXRAZOXANE FOR INJECTION | 78 | 0.1733 |
| 1 | DEXRAZOXANE HYDROCHLORIDE | 84 | 0.1690 |
| 2 | ERIBULIN MESYLATE | 413 | 0.1661 |
| 3 | DEXRAZOXANE | 108 | 0.1617 |
| 4 | RIBOCICLIB | 981 | 0.1437 |
| 5 | CEFTAROLINE FOSAMIL | 49 | 0.1175 |
| 6 | TRABECTEDIN | 161 | 0.1097 |
| 7 | POLATUZUMAB VEDOTIN | 81 | 0.1010 |
| 8 | GRANULOCYTE COLONY STIMULATING FACTOR | 207 | 0.0978 |
| 9 | MITOXANTRONE HYDROCHLORIDE | 373 | 0.0868 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 13312 |
| 1 | Platinum-based Drug [EPC] | 8856 |
| 2 | Alkylating Drug [EPC] | 8578 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 8226 |
| 4 | Kinase Inhibitor [EPC] | 7052 |
| 5 | Thalidomide Analog [EPC] | 6094 |
| 6 | Atypical Antipsychotic [EPC] | 5782 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 5127 |
| 8 | Microtubule Inhibitor [EPC] | 4784 |
| 9 | Nonsteroidal Anti-inflammatory Drug [EPC] | 4694 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Topoisomerase Inhibitor [EPC] | 2983 | 0.0740 |
| 1 | Estrogen Receptor Antagonist [EPC] | 1064 | 0.0693 |
| 2 | Human Immunoglobulin G [EPC] | 42 | 0.0660 |
| 3 | Platinum-based Drug [EPC] | 8856 | 0.0627 |
| 4 | CD30-directed Immunoconjugate [EPC] | 272 | 0.0603 |
| 5 | Alkylating Drug [EPC] | 8578 | 0.0602 |
| 6 | CD33-directed Immunoconjugate [EPC] | 142 | 0.0564 |
| 7 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 41 | 0.0537 |
| 8 | Microtubule Inhibitor [EPC] | 4784 | 0.0533 |
| 9 | Nucleoside Metabolic Inhibitor [EPC] | 8226 | 0.0527 |